Medicare Enrolled
Dr. Luke Barre, MD
Internal Medicine · Dartmouth, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barre from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barre?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barre
Dr. Luke Barre is an internal medicine specialist in Dartmouth, MA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Barre performed 17,538.6 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Barre received a total of $5,015 from 23 pharmaceutical and/or device companies across 241 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barre is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 0% volume in MA
$5,015 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,538.6
Medicare services
Top 0% in MA for internal medicine
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 6,600 | $18 | $43 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
3,625 | $34 | $70 |
| Infliximab-dyyb biosimilar injection, 10 mg An injection of infliximab-dyyb, a biosimilar medication, administered in a 10 mg dose. |
1,440 | $15 | $123 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
805 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
729 | $93 | $334 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
537.6 | $1 | $5 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
524 | $10 | $40 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
501 | $5 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
483 | $8 | $25 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
417 | $3 | $40 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
290 | $6 | $325 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
170 | $50 | $251 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
169 | $10 | $68 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
126 | $119 | $509 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
86 | $5 | $20 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
85 | $3 | $20 |
| Liver function blood test panel | 81 | $8 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
79 | $137 | $448 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
75 | $2 | $30 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
75 | $0 | $8 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
74 | $5 | $20 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
69 | $104 | $534 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
61 | $23 | $112 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
59 | $8 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
58 | $68 | $224 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
53 | $57 | $280 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
52 | $5 | $20 |
| Rheumatoid factor level | 50 | $6 | $20 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
50 | $56 | $255 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
49 | $4 | $20 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $87 | $333 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
22 | $6 | $20 |
| New patient office visit, complex (60-74 min) | 20 | $152 | $637 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.5% high complexity
52.2% medium
25.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,015
Total received (2018-2024)
Avg $716/year across 7 years
Top 16% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
241
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$676
2023
$675
2022
$886
2021
$960
2020
$575
2019
$915
2018
$328
Payments by company (2024)
ABBVIE INC.
$219
Amgen Inc.
$202
Janssen Biotech, Inc.
$80
GENZYME CORPORATION
$73
E.R. Squibb & Sons, L.L.C.
$28
AstraZeneca Pharmaceuticals LP
$27
GlaxoSmithKline, LLC.
$25
UCB, Inc.
$23
Top 3 companies account for 74.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,140
AbbVie Inc.
$666
Janssen Biotech, Inc.
$580
ABBVIE INC.
$489
GlaxoSmithKline, LLC.
$307
Lilly USA, LLC
$279
AbbVie, Inc.
$241
E.R. Squibb & Sons, L.L.C.
$210
Hikma Pharmaceuticals USA
$208
Genentech USA, Inc.
$149
AstraZeneca Pharmaceuticals LP
$126
Novartis Pharmaceuticals Corporation
$121
Alexion Pharmaceuticals, Inc.
$98
Horizon Therapeutics plc
$84
GENZYME CORPORATION
$73
Regeneron Healthcare Solutions, Inc.
$72
PFIZER INC.
$54
UCB, Inc.
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
West-Ward Pharmaceuticals
$15
Acorda Therapeutics, Inc
$13
Sunovion Pharmaceuticals Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 47.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · AVSOLA · BENLYSTA · BROVANA · COSENTYX · Cimzia · EVENITY · Enbrel · HUMIRA · Humira · INBRIJA · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Mitigare · OFEV · OLUMIANT · ORENCIA · Otezla · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIRIS · STELARA · Strensiq · TALTZ · TAVNEOS · TREMFYA · ULTOMIRIS · Ultomiris · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,015
County median income
$84,198
Nearest hospital to ZIP centroid (approximate)
SOUTHCOAST BEHAVIORAL HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barre is a mixed practice specialist, with above-average Medicare volume (top 0% in MA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barre experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Barre performed 6,600 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Barre receive payments from pharmaceutical companies?
Yes. Dr. Barre received a total of $5,015 from 23 companies across 241 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barre's costs compare to other internal medicine physicians in Dartmouth?
Dr. Barre's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barre) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Dartmouth
Browse internal medicine physicians in Dartmouth ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MA
Which MA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology